CD4 and Burkitt lymphoma: EBNA-1 can also be processed onto MHC class II for CD4+ T cells and in both in vitro system and a mouse model EBNA-1-specific CD4+ T cells have been shown to have the capacity to prevent BL development [15,16,17,18].